Thaitumu Marlene, Gkanali Vasiliki, Theodoridis Georgios, Gika Helen
Department of Medicine Aristotle University of Thessaloniki Thessaloniki Greece.
Biomic Center for Interdisciplinary Research and Innovation (CIRI-AUTH) Thessaloniki Greece.
Anal Sci Adv. 2025 Sep 14;6(2):e70044. doi: 10.1002/ansa.70044. eCollection 2025 Dec.
Bridging the gap between microsampling techniques and standard blood matrices presents a groundbreaking opportunity in metabolic biomarker analysis, offering minimally invasive, patient-centric alternatives to traditional venipuncture. This review presents the current knowledge obtained from the comparison of biomarkers analysis in liquid blood, plasma or serum in parallel to blood microsamples by targeted and untargeted metabolic profiling assays. It aims to explore the analytical performance of these approaches compared to conventional blood collection, emphasizing its efficacy in the field. Key challenges such as haematocrit effect and validation studies which are necessary steps for standardization and widespread clinical adoption are pointed out through examples in different applications. This review underscores the critical steps to employ the full potential of microsampling technologies for their integration in metabolic biomarker discovery and clinical diagnostics.
弥合微量采样技术与标准血液基质之间的差距,为代谢生物标志物分析带来了一个开创性的机遇,提供了比传统静脉穿刺更微创、以患者为中心的替代方法。本综述介绍了通过靶向和非靶向代谢谱分析方法,对液态血液、血浆或血清中的生物标志物分析与血液微量样本进行比较所获得的当前知识。其目的是探讨这些方法与传统血液采集相比的分析性能,强调其在该领域的有效性。通过不同应用中的实例,指出了诸如血细胞比容效应和验证研究等关键挑战,这些是标准化和广泛临床应用的必要步骤。本综述强调了充分发挥微量采样技术潜力以将其整合到代谢生物标志物发现和临床诊断中的关键步骤。